CA2017619A1 - Utilisation du naftopidil pour le traitement de la dysuree en cas d'hypertrophie benigne de la prostate - Google Patents

Utilisation du naftopidil pour le traitement de la dysuree en cas d'hypertrophie benigne de la prostate

Info

Publication number
CA2017619A1
CA2017619A1 CA2017619A CA2017619A CA2017619A1 CA 2017619 A1 CA2017619 A1 CA 2017619A1 CA 2017619 A CA2017619 A CA 2017619A CA 2017619 A CA2017619 A CA 2017619A CA 2017619 A1 CA2017619 A1 CA 2017619A1
Authority
CA
Canada
Prior art keywords
dysuria
naftopidil
therapy
cases
benign prostatic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2017619A
Other languages
English (en)
Other versions
CA2017619C (fr
Inventor
Gisbert Sponer
Ulrich Reicke
Michael Nelboeck-Hochstetter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6382247&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2017619(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Publication of CA2017619A1 publication Critical patent/CA2017619A1/fr
Application granted granted Critical
Publication of CA2017619C publication Critical patent/CA2017619C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
CA002017619A 1989-06-07 1990-05-28 Utilisation du naftopidil pour le traitement de la dysuree en cas d'hypertrophie benigne de la prostate Expired - Lifetime CA2017619C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP3918543.5 1989-06-07
DE3918543A DE3918543A1 (de) 1989-06-07 1989-06-07 Verwendung von naftopidil zur therapie der dysurie bei benigner prostata-hypertrophie

Publications (2)

Publication Number Publication Date
CA2017619A1 true CA2017619A1 (fr) 1990-12-07
CA2017619C CA2017619C (fr) 1995-06-20

Family

ID=6382247

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002017619A Expired - Lifetime CA2017619C (fr) 1989-06-07 1990-05-28 Utilisation du naftopidil pour le traitement de la dysuree en cas d'hypertrophie benigne de la prostate

Country Status (19)

Country Link
US (1) US5026706A (fr)
EP (1) EP0401653B1 (fr)
JP (1) JPH062673B2 (fr)
KR (1) KR0131452B1 (fr)
AT (1) ATE84416T1 (fr)
AU (1) AU625766B2 (fr)
CA (1) CA2017619C (fr)
DD (1) DD294864A5 (fr)
DE (2) DE3918543A1 (fr)
DK (1) DK0401653T3 (fr)
ES (1) ES2054147T3 (fr)
GR (1) GR3007328T3 (fr)
HK (1) HK46996A (fr)
HU (1) HU206976B (fr)
IE (1) IE62937B1 (fr)
IL (1) IL94601A (fr)
PH (1) PH26690A (fr)
PT (1) PT94268B (fr)
ZA (1) ZA904338B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474994A (en) * 1992-05-26 1995-12-12 Recordati S.A., Chemical And Pharmaceutical Company Bicyclic heterocyclic derivatives having α1 -adrenergic and 5HT1A
IT1254469B (it) * 1992-02-25 1995-09-25 Recordati Chem Pharm Derivati benzopiranici e benzotiopiranici
US6054432A (en) * 1996-09-12 2000-04-25 Asta Medica Aktiengesellschaft Means for treating prostate hypertrophy and prostate cancer
TW536402B (en) 1998-06-26 2003-06-11 Yamanouchi Pharma Co Ltd Pharmaceutical composition for the therapy of voiding dysfunction
PT1955700E (pt) 1999-09-30 2011-05-04 Harbor Biosciences Inc Tratamento terap?utico de doen?as associadas ao receptor de androg?nios
JP2001288115A (ja) * 2001-02-07 2001-10-16 Yamanouchi Pharmaceut Co Ltd 下部尿路症治療剤
BR102012000187A2 (pt) * 2012-01-05 2018-04-10 Univ Rio De Janeiro Derivados n-fenilpiperazínicos antagonistas de adrenoceptores a1a, a1d e de receptores 5-ht1a no tratamento da hiperplasia prostática benigna, composições farmacêuticas contendo os mesmos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL175059C (nl) * 1974-02-23 Boehringer Mannheim Gmbh Bereiding van bloeddrukverlagende stoffen en van preparaten die ze bevatten.

Also Published As

Publication number Publication date
JPH0324014A (ja) 1991-02-01
GR3007328T3 (fr) 1993-07-30
AU5628290A (en) 1990-12-13
DD294864A5 (de) 1991-10-17
CA2017619C (fr) 1995-06-20
US5026706A (en) 1991-06-25
ATE84416T1 (de) 1993-01-15
KR0131452B1 (ko) 1998-04-17
HU903515D0 (en) 1990-10-28
PH26690A (en) 1992-09-15
AU625766B2 (en) 1992-07-16
EP0401653B1 (fr) 1993-01-13
IL94601A (en) 1994-06-24
IL94601A0 (en) 1991-04-15
ZA904338B (en) 1991-03-27
DE59000748D1 (de) 1993-02-25
PT94268B (pt) 1997-01-31
ES2054147T3 (es) 1994-08-01
EP0401653A2 (fr) 1990-12-12
HUT54494A (en) 1991-03-28
IE902014L (en) 1990-12-07
PT94268A (pt) 1991-02-08
HU206976B (en) 1993-03-01
DK0401653T3 (da) 1993-03-29
DE3918543A1 (de) 1990-12-13
HK46996A (en) 1996-03-22
EP0401653A3 (fr) 1991-07-17
JPH062673B2 (ja) 1994-01-12
DE3918543C2 (fr) 1991-06-06
IE62937B1 (en) 1995-03-08
KR910000152A (ko) 1991-01-29

Similar Documents

Publication Publication Date Title
AU7010694A (en) A surgical instrument, particularly for operative treatment of the prostate gland
EA200000220A1 (ru) Сочетание ингибитора тирозинкиназы и химической стерилизации для лечения рака предстательной железы
GR3018541T3 (en) Condensed heterocyclic compounds and their use in therapy.
EP0407780A3 (en) Ranolazine and related piperazines used in the treatment of tissues experiencing a physical or chemical insult
AU6998787A (en) Transglutaminase inhibitors
SE8104625L (sv) Anvending av aromatas-hemmare for profylax och terapi av prostatahyperplasi
ATE130589T1 (de) Verwendung von wässrigen kationischen kunststoffdispersionen zum imprägnieren und grundieren von saugfähigen substraten.
CA2017619A1 (fr) Utilisation du naftopidil pour le traitement de la dysuree en cas d'hypertrophie benigne de la prostate
DK504389A (da) Adjuveret antigenoploesning, dens fremstilling samt zink- eller jernhydroxidgel til anvendelse derved
WO1993013207A3 (fr) Nouvelles transglutaminases humaines
PT971710E (pt) Utilizacao de queleritrina e radiacao para terapia de tumores
KR20010012505A (ko) 양성 전립선 과형성의 치료에 유용한 아릴 치환된 피페라진
DK437886A (da) Makrocycliske antibiotika samt deres fremstilling og anvendelse
EP0350738A3 (fr) (S)-emopamil employée dans le traitement de la migraine
WO2000035920A3 (fr) 4,5-azolo-oxindoles
AU4482985A (en) Pyrro-1-yl-phenyl-dihydropyridazones
GB9214754D0 (en) Tumour treatment
SE8500845L (sv) Forfarande for framstellning av glyoxylylspermidin och anvendningen derav for framstellning av 15-deoxispergualin-beslektade foreningar
AU6790987A (en) Heptanoyl-glu-asp-ala-amino acid immunostimulants
ZA877900B (en) Active compounds for preventing tumor metastases
GB2360785A8 (en) 2-Aza-21-carbaporphyrins (N-confused porphyrins) with (hydroxy/alkoxy)phenyl meso-substituents for photodynamic therapy & the treatment of tumours
NO923094D0 (no) Framgangsmaate for bestemmelse av arten av og distribusjonen av vevstyper i levende organismer, saerlig matinnhold i f.eks krabber
AU613510B2 (en) Use of zofenopril for the treatment of rheumatoid arthritis
FR2517679B1 (fr)
AU7680187A (en) Epoxy oligosaccharides

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed
MKEC Expiry (correction)

Effective date: 20121202